Advice Pool - Health and Fitness

Blood is the life-maintaining fluid that circulates through the heart, arteries, veins, and capillaries. Because the blood performs many and

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

complex functions, there are many disorders related to blood that require clinical care by a physician or other health care professional. T

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

hese conditions include anemia, bleeding disorders, as well as cancers of the blood.

Certain factors may cause Blood Disorders, disorders t

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

hat affect the cells in the blood (blood cells) or proteins in the blood clotting or immune systems. Laboratory tests of blood samples are r

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ecommended to diagnose and monitor blood diseases. Because the liquid portion of the blood (plasma) carries so many substances essential to

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

the functioning of the body, blood tests can be used to find out what is happening in many parts of the body.

There are a number of Blood D

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

isorders prevailing these days. Some of them are Anemia, Pernicious Anemia, Sepsis, Sickle Cell Anemia, Hypoglycemia, Iron Deficiency Anemia

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

and Leukemia.

Different type of Blood Disorder shows different symptom. Symptoms of blood disorders are often vague and nonspecific, that i

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

s, they could indicate a disorder of almost any part of the body. However, although no single symptom unmistakably indicates a blood disorde

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

r, certain groups of symptoms suggest the possibility. Such groups of symptoms most commonly relate to decrease in blood cells, such as a re

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

duced number of red blood cells (anemia), a reduced number of white blood cells, a reduced number of platelets or increased numbers of blood

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

cells.

Disorders of substances (factors) responsible for normal blood clotting may result in insufficient blood clotting (manifesting as e

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

xcessive bruising or bleeding or as small red or purple spots on the skin) or in the formation of abnormal blood clots (producing warm, pain

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ful areas in the legs or sudden shortness of breath, chest pain, or both). These problems may arise because the body does not produce enough

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

of these factors, the factors are abnormal, or the body is using up the factors too quickly.

Doctors may prescribe different treatment opti

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ons according to the type and stage of Blood Disorder. A number of treatment options are being suggested like bone marrow transplant, stem c

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ell transplant, Blood Transfusion, Chemotherapy etc.

When you think of a transplant, you may have an image of a major surgical procedure to

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

replace a diseased organ. But stem cell transplants do not involve surgery. And the "organ" involved is bone marrow — not a solid organ suc

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

h as a liver.

A stem cell transplant is the infusion of healthy stem cells into your body. If all goes well, these healthy stem cells take

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

hold in your body and begin normal production of blood cells.

Treatment becomes less complex if the disorder is diagnosed at an early stage

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/241928/advicepool-Blood-DiseasesSymptoms-Causes-and-Treatment.html">Blood Diseases-Symptoms, Causes and Treatment</a>

BB link (for phorums):
[url=http://www.advicepool.org.ua/article/241928/advicepool-Blood-DiseasesSymptoms-Causes-and-Treatment.html]Blood Diseases-Symptoms, Causes and Treatment[/url]

Physician Expense Insurance – sometimes called the regular medical expense insurance - is a form of health insurance that covers the expenses incurred on the services of a physician other than surger...

Moreover, the amount to be paid is a mere drop in the ocean and won't threaten their bottom line. The stepped-up naval patrols and aerial surveillance by Malaysia, Indonesia and Singapore have been effective in reducing piracy, but these are expensive affairs and so are the buoys, lighthouses and other navigation aids, and the measures to clean up oil spills. Since the littoral states have taken purposeful measures to come to grips with the issues of safety, security and pollution, it is incumbent on the international maritime community to lend them a hand. It is time the shipping industry took on board the idea that it too should contribute financially to the upkeep of one of the world’s busiest sea lanes.

Tags

Links

Advice Pool - Blood Diseases-Symptoms, Causes and Treatment

Related Articles: